Long Liu

9PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsMajor global burdens of diseaseImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 20, 2026
A Programmable Calcification Nanoplatform for Loco-Regional Calcification-Immune Hepatocellular Carcinoma Therapy.

|Jul 08, 2026
Macrophage-Induced Senescent Cancer-Associated Fibroblasts Promote SASP-Mediated Chemoresistance in Colorectal Cancer.

|Jun 03, 2025
Genome-Scale CRISPR-Cas9 Analysis Reveals Tumor Heterogeneity and Identifies NDC80 as Novel Biomarker in HCC.

Zhipu Liu, Long Liu, Shutong Liu

|Dec 08, 2023
Associations Between Life's Essential 8 and Chronic Kidney Disease.

Yuqing Ren, Zongao Cai, Chunguang Guo

|Nov 22, 2023
AARS2 as a novel biomarker for prognosis and its molecular characterization in pan-cancer.

Long Liu, Jie Gao, Xudong Liu

|Apr 12, 2023
LATS-regulated nuclear-cytoplasmic translocation of SREBP2 inhibits hepatocellular carcinoma cell migration and invasion via epithelial-mesenchymal transition.

Feng Zhang, Jie Gao, Xudong Liu

Pageof 2

Frequent Collaborators

5 joint publications

Xinwei Han

4 joint publications

Zaoqu Liu

3 joint publications

Libo Wang

2 joint publications

Yuyuan Zhang